Novo Nordisk Other Long Term Liabilities (Quarterly) Trends

Novo Nordisk A/S (NVO)

58.59 -1.05 (-1.76%) USD | NYSE | Jan 14, 13:06

View Other Long Term Liabilities (Quarterly) for NVO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Ascendis Pharma A/S	--
Evaxion AS	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Omeros Corp.	Upgrade
Viking Therapeutics, Inc.	--